Afrigen Biologics
Blood & Organ Banks · South Africa · 11-50 Employees
View Company Info for Free
Overview
Headquarters
unit 5 Kestrel Park Longclaw Dr, Cape To...Phone Number
+27 212070101Website
www.afrigen.co.zaRevenue
<$5 MillionIndustry
About Afrigen Biologics
Afrigen Biologics Org Chart
Manager, Production
Manager, Quality Control & Laboratories
Manager, Production
Supervisor, QC Analytical
Is Afrigen Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Afrigen Biologics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Afrigen Biologics recently announced quarterly report
Click to see if Afrigen Biologics had a recent Job posting/layoffs
Afrigen Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Afrigen Biologics launches new products
Check out if Afrigen Biologics is spiking on competitors!
Check if Afrigen Biologics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Afrigen Biologics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Afrigen Biologics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Afrigen Biologics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Afrigen Biologics.
Afrigen Biologics Tech Stack
A closer look at the technologies used by Afrigen Biologics
Most Recent Scoops
Afrigen Biologics News & Media
Curapath Announces Collaboration with Afrigen Biologics to Advance Development of African-owned mRNA SARS-CoV-2 Vaccine
VALENCIA, Spain & BOSTON--(BUSINESS WIRE)--Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid- and lipid-based nanoparticle delivery systems for therapeutics and vaccines, today announced a collaboration with Afrigen Biologics to advance the development of the first African-owned mRNA SARS-Cov-2 vaccine. Under the collaboration, Curapath will be responsible for development of a scaled-up manufacturing process of the nanoparticle formulation for the vaccineU.S. Vaccine Tech Transfer to Africa a Win for Global Health, says AHF
LOS ANGELES--(BUSINESS WIRE)-- #COVID19--AIDS Healthcare Foundation (AHF) today praised the U.S. National Institutes of Health (NIH) for committing to share innovative technologies with a South Africa-based biotech company, Afrigen, which should speed up the development and rollout of modern, highly-effective vaccines in low- and middle-income countries, including on the African continent. “We have entered a new age of pandemics, which demands a new way of fighting infectious diseases. As we hav
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Afrigen Biologics
Afrigen Biologics is a biotechnology company based in Cape Town that focuses on building mRNA vaccine production capacity in low- and middle-income countries through a technology transfer hub. The company offers a range of services including vaccine development, encapsulation technologies, and compounding solutions aimed at improving therapeutic de... Read More